Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series
Our findings suggest that PGx testing can guide prescribing decisions for patients with antidepressant ineffectiveness or ADRs. The relatively high prevalence of genetic variants affecting pharmacokinetics supports the broader adoption of PGx testing in psychiatric practice.
Authors
- Bertrand Lahutte
- Emeric Saguin (ORCID: https://orcid.org/0000-0001-7033-2340)
- Antoine Baldacci (ORCID: https://orcid.org/0000-0003-3505-5303)
- Gilles Sipahimalani
- Hervé Delacour (ORCID: https://orcid.org/0000-0002-1150-0209)
- Marie-Agnès Lorvellec
Institutions
- Hôpital d'Instruction des Armées Bégin (FR)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.3389/fphar.2024.1440523
- Citations
- 7
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.27
Funders
- Academy of Military Medical Sciences